XT
EWTX icon

XTX Topco’s Edgewise Therapeutics EWTX Stock Holding History

XTX Topco’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Buy
45,832
+26,724
+140% +$921K 0.02% 1177
2026
Q1 		$602K Sell
19,108
-36,512
-66% -$1.05M 0.01% 1852
2025
Q4 		$1.38M Buy
+55,620
New +$1.12M 0.04% 795
2025
Q3 		– Sell
-60,739
Closed -$796K – 2761
2025
Q2 		$796K Buy
+60,739
New +$876K 0.03% 805
2024
Q4 		– Sell
-28,303
Closed -$755K – 2459
2024
Q3 		$755K Buy
+28,303
New +$563K 0.05% 560
2024
Q2 		– Sell
-14,049
Closed -$256K – 2039
2024
Q1 		$256K Sell
14,049
-3,094
-18% -$49.2K 0.03% 981
2023
Q4 		$188K Buy
17,143
+5,191
+43% +$36.4K 0.04% 988
2023
Q3 		$68.5K Buy
+11,952
New +$81.2K 0.01% 1234

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

XTX Topco's EWTX Position: Q2 2026 in Review

XTX Topco increased its Edgewise Therapeutics (EWTX) stake by 140% in Q2 2026, buying an estimated $921K and bringing the position to 45,832 shares worth $1.86M. The position accounts for 0.02% of the portfolio, ranked #1177.

XTX Topco first reported a position in EWTX in Q3 2023 and has held it in 8 quarters since. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • XTX Topco held 45,832 shares of Edgewise Therapeutics worth $1.86M as of Q2 2026.
  • XTX Topco bought 26,724 Edgewise Therapeutics shares in Q2 2026, an estimated $921K.
  • Edgewise Therapeutics made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1177 holding.
  • XTX Topco first reported a position in Edgewise Therapeutics in Q3 2023 and has held it in 8 quarters since.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.